NEUROZYM BIOTECH AS

7760 SNÅSA

Finances

Return on Equity

18,13 %

Current Ratio

33,36

Debt-to-Equity Ratio

−12,99

Key figures (NOK)	2022	2021	2020	2019
Revenue	360 000	584 000	575 000	849 000
Net Income	−58 000	113 000	33 000	−315 000
Total Assets	3 905 000	3 879 000	3 678 000	3 984 000
Total Equity	−320 000	−261 000	−374 000	−407 000

Income (NOK)	2022	2021	2020	2019
Revenue	360 000	584 000	575 000	849 000
Expenditure	439 000	474 000	542 000	1 160 000
Operating Profit	−79 000	109 000	33 000	−312 000
Financial Income	21 000	4 000	9 000	10 000
Financial Costs	0	0	9 000	13 000
Financial Balance	21 000	4 000	0	−3 000
Earnings Before Tax	−58 000	113 000	33 000	−315 000
Tax	0	0	0	0
Net Income	−58 000	113 000	33 000	−315 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 670 000	1 674 000	1 700 000	1 737 000
Total Current Assets	2 235 000	2 205 000	1 978 000	2 247 000
Total Assets	3 905 000	3 879 000	3 678 000	3 984 000
Total Retained Equity	−1 511 000	−1 453 000	−1 566 000	−1 599 000
Total Equity	−320 000	−261 000	−374 000	−407 000
Total Long-Term Debt	4 158 000	4 026 000	4 007 000	4 002 000
Total Current Debt	67 000	114 000	46 000	390 000
Total Equity and Debt	3 905 000	3 879 000	3 678 000	3 984 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	359 000	486 000	564 000	849 000
Other Income	0	98 000	11 000	0
Revenue	360 000	584 000	575 000	849 000
Cost of Goods Sold	69 000	55 000	96 000	115 000
Salary Costs	178 000	171 000	67 000	571 000
Depreciation	4 000	26 000	37 000	47 000
Impairment	0	0	0	0
Expenditure	439 000	474 000	542 000	1 160 000
Operating Profit	−79 000	109 000	33 000	−312 000
Financial Income	21 000	4 000	9 000	10 000
Financial Costs	0	0	9 000	13 000
Financial Balance	21 000	4 000	0	−3 000
Dividends	0	0	0	0
Net Income	−58 000	113 000	33 000	−315 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	24 000	24 000	24 000	24 000
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	25 000	29 000	55 000	92 000
Total Tangible Assets	25 000	29 000	55 000	92 000
Total Fiancial Fixed Assets	1 621 000	1 621 000	1 621 000	1 621 000
Total Fixed Assets	1 670 000	1 674 000	1 700 000	1 737 000
Stock	0	68 000	120 000	59 000
Total Investments	0	0	0	0
Cash, Bank	2 228 000	2 067 000	1 826 000	2 139 000
Total Current Assets	2 235 000	2 205 000	1 978 000	2 247 000
Total Assets	3 905 000	3 879 000	3 678 000	3 984 000
Total Equity	−320 000	−261 000	−374 000	−407 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	4 158 000	4 026 000	4 007 000	4 002 000
Creditors	0	1 000	11 000	39 000
Unpaid Taxes	37 000	64 000	8 000	18 000
Dividends	0	0	0	0
Other Current Debt	30 000	49 000	26 000	332 000
Total Current Debt	67 000	114 000	46 000	390 000
Total Equity and Debt	3 905 000	3 879 000	3 678 000	3 984 000

Financial indicators	2022	2021	2020	2019
Return on Equity	18,13 %	−43,3 %	−8,82 %	77,4 %
Debt-to-Equity Ratio	−12,99	−15,43	−10,71	−9,83
Operating Profit Margin	−21,94 %	18,66 %	5,74 %	−36,75 %
Current Ratio	33,36	19,34	43	5,76
Quick Ratio	33,36	47,93	−26,73	6,79
Equity Ratio	−0,08	−0,07	−0,1	−0,1
Gross Profit Margin	80,83 %	90,58 %	83,3 %	86,45 %